Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 47 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Therapeutic drug monitoring of everolimus: a consensus reportShipkova, M.; Hesselink, D.; Holt, D.; Billaud, E.; Van Gelder, T.; Kunicki, P.; Brunet, M.; Budde, K.; Barten, M.; De Simone, P.; Wieland, E.; Lopez, O.; Masuda, S.; Seger, C.; Picard, N.; Oellerich, M.; Langman, L.; Wallemacq, P.; Morris, R.; Thompson, C.; et al.
1995Best Practice in Therapeutic Drug MonitoringTett, Susan Elizabeth; Ray, J.; Morris, R.
2013Mass or molar? Recommendations for reporting concentrations of therapeutic drugsJones, G.; Bryant, S.; Fullinfaw, R.; Ilett, K.; Miners, J.; Morris, R.; Doogue, M.
2010Does liquid chromatography-tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?Taylor, P.; Morris, R.
2008Measuring the unbound concentration fails to resolve analytic interferences in digoxin immunoassaysMorris, R.; Jones, T.; Wicks, F.; Rogers, N.
2001Cyclosporin monitoring - state of the art?Morris, R.; Russ, G.
2010Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional developmentNorris, R.; Martin, J.; Thompson, E.; Ray, J.; Fullinfaw, R.; Joyce, D.; Barras, M.; Jones, G.; Morris, R.
2010Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriberRogers, N.; Jones, T.; Morris, R.
2004Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady stateJones, T.; Morris, R.; Horowitz, J.
2005CEDIAƒ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimensWestley, I.; Morris, R.; Taylor, P.; Salm, P.; James, M.